(Q36549794)

English

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure

scientific article published on October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Anthony E Lang

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1

object named as

Susan H Fox

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Jonathan M. Brotchie

3

object named as

Jonathan M Brotchie

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1578-1594

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

The MPTP-treated primate as a model of motor complications in PD: primate model of motor complications

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Levodopa-induced dyskinesias are improved by fluoxetine

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Adenosine A(2A) receptor antagonist treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20936

21 January 2018

Identifiers

10.1002/MDS.20936

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36549794&oldid=1637532625"